Brief: Biotec Pharmacon Q2 EBITDA Loss Narrows To NOK 4.2 Mln
16/08/2018 06:07
Aug 16 (Reuters) - Biotec Pharmacon ASA BIOTEC.OL :
* REPORTED SALES OF NOK 10.9 MILLION (16.4) IN Q2 OF 2018
* Q2 NEGATIVE EBITDA OF NOK 4.2 MILLION (-4.4)
* ARCTICZYMES GENERATED SALES OF NOK 5.7 MILLION DURING Q2
Source text for Eikon: ID:nWkr9Nz8lg
Further company coverage: BIOTEC.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))